A Japanese-American woman with advanced Alzheimer’s disease showed noticeable improvements after she took a high dose of magic mushrooms in a case study.
As usual, a case study is basically the bottom of the barrel you can get for efficacy of a treatment that’s still published science. It doesn’t mean it’s bad science (it can often be quite useful for establishing future studies); it just means that it really shouldn’t be advertised to the general public until there’s e.g. a good meta-analysis.
I wish the qualities of evidence tiers were taught in (at least) high school. Especially as so much information is increasingly at our fingertips. That plus moral philosophy.
As usual, a case study is basically the bottom of the barrel you can get for efficacy of a treatment that’s still published science. It doesn’t mean it’s bad science (it can often be quite useful for establishing future studies); it just means that it really shouldn’t be advertised to the general public until there’s e.g. a good meta-analysis.
Anyway, with that said, here’s a link to the case study since CTV’s seems to be malformatted.
I wish the qualities of evidence tiers were taught in (at least) high school. Especially as so much information is increasingly at our fingertips. That plus moral philosophy.